Related Experiment Video
Updated: Jan 20, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
A Rare Case of Recurrent Lower Extremity Ulcer
1Southwest Hospital, Army Medical University, Chongqing, China.
Venous leg ulcers in an elderly patient were successfully treated by addressing underlying Budd-Chiari syndrome. Multidisciplinary care resolved chronic venous disorder and inferior vena cava stenosis, healing refractory leg ulcers.
Area of Science:
- Vascular Surgery
- Hepatology
- Dermatology
Background:
- Venous leg ulcers stem from chronic venous disorder and venous hypertension, presenting complex treatment challenges.
- Standard treatments include medication, compression therapy, and surgery, with varying success rates.
- Budd-Chiari syndrome, a rare condition causing portal and/or inferior vena cava hypertension, requires specialized management.
Observation:
- An elderly female patient presented with recurrent, poorly healing lower extremity ulcers despite prolonged conventional treatment and skin grafting.
- Further investigation revealed the patient had Budd-Chiari syndrome.
- The patient's venous leg ulcers were refractory to standard treatments.
Findings:
- The patient's Budd-Chiari syndrome involved inferior vena cava stenosis.
- Multidisciplinary treatment focused on resolving the inferior vena cava stenosis.
- Surgical intervention to address venous hypertension and wound management led to ulcer healing.
Implications:
- This case highlights the importance of investigating rare underlying conditions like Budd-Chiari syndrome in refractory venous leg ulcers.
- Successful management of Budd-Chiari syndrome can lead to the resolution of severe venous leg ulceration.
- Integrated, multidisciplinary approaches are crucial for complex vascular and dermatological conditions.
Related Concept Videos
07:06Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
08:28Targeted Metabolomics on Rare Primary Cells
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
06:51Mouse Model of Pressure Ulcers After Spinal Cord Injury
Absolute and Local Extreme Values
05:25Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

